Who is sponsoring NCT04345835?

NCT04345835 is sponsored by Kafrelsheikh University.

What drugs are being tested in NCT04345835?

Interventions in NCT04345835: Percutanous nephrolithotomy (PCNL).

What condition does NCT04345835 study?

NCT04345835 studies Renal Stones.

Is NCT04345835 still recruiting?

NCT04345835 is currently completed. Last updated 15 April 2020.

Last reviewed 2020-04-15 · How we verify

NCT04345835

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prone Flexed Position in Percutanous Nephrolithotomy

Completed NA Last updated 15 April 2020

What this trial tests

NA trial testing Percutanous nephrolithotomy (PCNL) in Renal Stones in 300 participants. Completed in 1 April 2020.

Timeline

1 April 2018

Primary endpoint
1 April 2020

1 April 2020

Quick facts

Lead sponsor	Kafrelsheikh University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	300
Start date	1 April 2018
Primary completion	1 April 2020
Estimated completion	1 April 2020
Sites	1 location across Egypt

Drugs / interventions tested

Percutanous nephrolithotomy (PCNL)

Conditions studied

Renal Stones — all drugs for Renal Stones →

Sponsor

Kafrelsheikh University

Who can join

Adults 18 to 70, any sex, with Renal Stones. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

prone flexed position in percutanous nephrolithotomy in comparsion with standard prone position. A randomized controlled trial.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Prone versus prone-flexed position in percutaneous nephrolithotomy: A randomized controlled trial.
Taha DE, Ibrahim A, Zeid A, Shokry E, et al · · 2025 · PMID 40051992 · DOI 10.4103/ua.ua_36_24

Verify or expand the search:

Other Kafrelsheikh University trials

Trials by the same sponsor.

NCT07585396 — Inositol in Letrozol Resistant PCOS Women · Phase 2, PHASE3 · not yet recruiting
NCT07433920 — L-PRF Versus Sticky Bone Grafting of the Jumping Gap in AI-assisted Computer-Guided Socket Shield Immediate Implantation · NA · recruiting
NCT07368348 — Evaluation of Internal Nasal Splint-Supported Free Graft Versus Nasoseptal Flap for Endoscopic Skull Base Repair in Cere · NA · recruiting
NCT07348094 — Guided Lateral Sinus Lifting Using Autologous Serum Albumin/Platelet-Rich Fibrin · NA · recruiting
NCT07359144 — Pilates Exercises on Nonspecific Low Back Pain in Postnatal Women · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04345835 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kafrelsheikh University
Last refreshed: 15 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04345835.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing